Wakatsuki, T.
244  results:
Search for persons X
?
1

Safety and efficacy of first-line nivolumab plus chemothera..:

Shimozaki, K. ; Fukuda, K. ; Ooki, A....
ESMO Gastrointestinal Oncology.  5 (2024)  - p. 100072 , 2024
 
?
2

Real-world outcomes of trifluridine/tipiracil for heavily p..:

Fukuda, K. ; Nakayama, I. ; Ooki, A....
ESMO Gastrointestinal Oncology.  3 (2024)  - p. 100046 , 2024
 
?
3

Two-year outcomes of drug-coated balloon only strategy for ..:

Bando, R ; Wakatsuki, T ; Yamaguchi, K...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
 
?
7

Early and chronic phased local coagulative responses follow..:

Yamaguchi, K ; Wakatsuki, T ; Okushi, Y...
European Heart Journal.  42 (2021)  Supplement_1 - p. , 2021
 
?
9

Prediction of a single Gaussian shape of spectral line meas..:

Kin, F. ; Nakano, T. ; Oyama, N....
Review of Scientific Instruments.  92 (2021)  5 - p. , 2021
 
?
10

Toll-like receptor 9 is a novel therapeutic target to preve..:

Soeki, T ; Matsumoto, K ; Fukuda, D...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
 
?
11

P1526 Updated prevalence of lambls excrescences using the l..:

Takahashi, T ; Kusunose, K ; Hayashi, S...
European Heart Journal - Cardiovascular Imaging.  21 (2020)  Supplement_1 - p. , 2020
 
?
12

P2813The improvement of chronic local coagulative response ..:

Yamaguchi, K ; Wakatsuki, T ; Ueno, R...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
 
?
 
?
14

P2867Vildagliptin reduces inducibility of atrial fibrillati..:

Soeki, T ; Matsumoto, K ; Fukuda, D...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
 
1-15